Source: Annual Congress 2003 - Interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Tachibana, T. Johhkoh, K. Nakata, T. Ishida, S. Abe (Osaka, Suita, Tokyo, Kurasiki, Sapporo, Japan). Long clinical course of pulmonary alveolar microlithiasis in Japan. Eur Respir J 2003; 22: Suppl. 45, 1330

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics of pulmonary alveolar microlithiasis in Japan Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan Source: Eur Respir J 2011; 37: 465 Year: 2011 Pulmonary alveolar microlithiasis Source: Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020 Year: 2020 Pulmonary alveolar microlithiasis Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Long term follow-up in patients with pulmonary alveolar proteinosis Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Pulmonary alveolar microlithiasis (PAM) Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 New mutation associated to the pulmonary alveolar microlithiasis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Pulmonary alveolar microlithiasis: case report Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Pulmonary alveolar microlithiasis: a case report Source: Eur Respir J 2004; 24: Suppl. 48, 489s Year: 2004 First presentation of a case of pulmonary alveolar microlithiasis with spontaneous pneumothorax Source: Annual Congress 2012 - The good clinical practice: useful case report Year: 2012 Fatal cases of pulmonary alveolar proteinosis: a nationwide surveillance in Japan Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Pulmonary alveolar microlithiasis: no longer in the stone age Source: ERJ Open Res, 6 (3) 00289-2020; 10.1183/23120541.00289-2020 Year: 2020 Clinical and paraclinical manifestations of pulmonary alveolar proteinosis in children Source: Eur Respir J 2007; 30: Suppl. 51, 402s Year: 2007 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way Year: 2009 Autoimmune pulmonary alveolar proteinosis complicated with infections: a nationwide surveillance study in Japan Source: International Congress 2017 – Rare diseases Year: 2017